<DOC>
	<DOCNO>NCT01545297</DOCNO>
	<brief_summary>Awake craniotomy resection brain tumor locate close proximity area eloquent brain function , speech , motor sensory , accepted procedure use minimize neurological injury resection . During awake craniotomy , anesthesia usually provide use combination local anesthesia ( regional scalp block and/or local infiltration ) intravenous ( IV ) agent provide sedation , anxiolysis analgesia . Propofol sedation , commonly combination shorter act opioid fentanyl , remifentanil , effective popular technique awake craniotomy , achieve high degree patient satisfaction acceptance . Most anesthetic agent associated respiratory depression . The anesthetic agent call dexmedetomidine potent , highly selective α2-adrenoceptor agonist . The effect dexmedetomidine anxiolysis , analgesia , sedation sympatholysis , associate respiratory depressive effect . Bekker et al . first report successful use dexmedetomidine awake craniotomy 2001 . The purpose blind , prospective , randomize study compare efficacy dexmedetomidine versus propofol-remifentanil base sedation patient undergo awake craniotomy resection tumor . The study hypothesis efficacy perform intra-operative brain mapping identical dexmedetomidine propofol-remifentanil base sedation . The primary end-points assess ability perform intraoperative map awake craniotomy . Secondary end-points assess incidence complication ( respiratory depression , failure provide adequate analgesia ) , well patient surgeon satisfaction correspond anesthetic technique .</brief_summary>
	<brief_title>Comparison Dexmedetomidine Propofol-Remifentanil Conscious Sedation Awake Craniotomy Tumor Surgery</brief_title>
	<detailed_description>Awake craniotomy resection brain tumor locate close proximity area eloquent brain function , speech , motor sensory , accepted procedure use minimize neurological injury resection . The level sedation analgesia different stage surgery varies , importantly , patient need awake alert brain mapping . During awake craniotomy , anesthesia usually provide use combination local anesthesia ( regional scalp block and/or local infiltration ) intravenous ( IV ) agent provide sedation , anxiolysis analgesia . There considerable variation anesthetic management awake craniotomy different institution . Propofol sedation , commonly combination shorter act opioid fentanyl , remifentanil , effective popular technique awake craniotomy , achieve high degree patient satisfaction acceptance . However , awake craniotomy remain one challenging technique anesthesia care term balance adequate depth sedation analgesia combat rapid change surgical stimulation yet alert patient brain mapping . Furthermore , anesthetic agent associated respiratory depression . A new anesthetic agent call dexmedetomidine ( Precedex ( TM ) , Hospira Healthcare Corporation , Saint Laurent , Québec , Canada ) potent , highly selective α2-adrenoceptor agonist α2 : α1 selectivity ratio 1600:1 . It available Canada since 2009 short-term sedative agent , available UHN . The use dexmedetomidine mechanically ventilate patient ICU intra-operative sedation . The well-documented beneficial effect dexmedetomidine anxiolysis , analgesia , sedation sympatholysis , associate respiratory depressive effect . Dexmedetomidine successfully use provide sedation dental procedure , awake fibreoptic intubation , bariatric surgery morbidly obese patient , well obstructive sleep apnea patient . The pharmacokinetic property dexmedetomidine predictable titratable , rapid distribution half-life ( t1/2α ) approximately 5-6min elimination half-life ( t1/2β ) approximately 2h . Bekker et al . first report successful use dexmedetomidine awake craniotomy 2001 . Subsequent case series publish Souter et al . demonstrated dexmedetomidine use either sole agent combination agent fentanyl seizure foci resection accurate intraoperative brain mapping . The hypnotic effect dexmedetomidine mediate hyperpolarization noradrenergic neuron locus ceruleus , propose dexmedetomidine converge natural sleep pathway exert sedative effect . Venn co-worker , part large European multicentre trial investigate dexmedetomidine postoperative sedation ICU , report : `` Patients calmly easily rouse sleep allow excellent communication cooperation intubate ventilate , similarly quickly return sleep '' . This unique sedation state useful awake craniotomy , require deep level sedation painful operative procedure , well easily rousable state mapping eloquent function . The purpose blind , prospective , randomize study compare efficacy dexmedetomidine versus propofol-remifentanil base sedation patient undergo awake craniotomy resection tumor . The study hypothesis efficacy perform intra-operative brain mapping identical dexmedetomidine propofol-remifentanil base sedation . The primary end-points assess ability perform intraoperative map awake craniotomy . Secondary end-points assess incidence complication ( respiratory depression , failure provide adequate analgesia ) , well patient surgeon satisfaction correspond anesthetic technique .</detailed_description>
	<mesh_term>Propofol</mesh_term>
	<mesh_term>Dexmedetomidine</mesh_term>
	<mesh_term>Remifentanil</mesh_term>
	<criteria>Adult patient 18 year age . ASA score I , II III . Patients schedule undergo awake craniotomy elective tumor resection . Patients allergy drug use . Patients pregnant . Patients alcohol substance abuse . Patients able understand instruction awake craniotomy question regard intraoperative pain , postoperative satisfaction . Lack informed consent .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>dexmedetomidine</keyword>
	<keyword>conscious sedation</keyword>
	<keyword>awake craniotomy</keyword>
	<keyword>brain mapping</keyword>
</DOC>